Search

everythinglearnresearchcommunity

for

Search:↓

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

High uric acid can cause health problems, but lifestyle changes can help manage it.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Oral cyclosporin doesn't stop hair loss.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Hair dye can cause severe scalp burns and long-term health risks, so safety guidelines must be followed.

Feathers are useful for researching growth, regeneration, and the effects of treatments like chemotherapy on hair loss.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

New nanocarriers improve drug delivery for disease treatment.

Reducing reactive oxygen species can help treat nerve damage from platinum cancer drugs.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Nanoparticles have diverse applications, including promising cancer treatments and hair growth solutions.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

The compounds tested could potentially treat hair loss and alopecia.

Caffeine may benefit skin and hair health but more research is needed to confirm its effectiveness in dermatology.

Microneedles could be a better and easier way to regrow hair.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.